On May 19, 2020, Roche announced its Elecsysﾮ Anti-SARS-CoV-2 antibody test is live at more than 20 commercial and hospital lab sites throughout the U.S., with plans in the next several weeks to increase to more than 200 commercial and hospital lab sites with the ability to perform millions of tests per week. The Elecsysﾮ Anti-SARS-CoV-2 antibody test received Emergency Use Authorization from the FDA earlier this month.